Table 5. Overall studies reporting on prevalence (%) of health anxiety by chronic illness.
Disease (k) | Mode of determination (k) | Range of prevalence | Author | Reported prevalence | Determination of prevalence scores |
---|---|---|---|---|---|
Cancer (58) | 0–86 | ||||
Cut-off (20) | 4.3–70 | Aghdam et al., 2014 [31] | 49.6 | Scale literature on FoP-Q-SF for “high FoP” | |
Anderson et al., 2014 [134] | 8 | Scale literature cut-off for MAX-PC for “clinical fear of recurrence” | |||
Butow et al., 2014 [32] | 44 | Scale literature on FCRI for “clinical fear of cancer recurrence” | |||
Custers et al., 2013 [135] | 51 | Scale literature on CWS for "high fear of recurrenc" | |||
Custers et al., 2014 [33] | ROC curve determing cut-off for high fear of recurrence for the CWS using 2-item CAS | ||||
31 | CWS | ||||
40 | CAS | ||||
Dinkel et al., 2014 [35] | 20 | 80th percentile on FoP-Q determined by authors | |||
Ghazali et al., 2013 [36] | 35 | Established algorithm on 7-item scale identifying “significant fear of recurrence” | |||
Halbach et al., 2016 [140] | 16.9 | 1 SD above the mean on the FoP-Q-SF | |||
Hefner et al., 2016 [150] | 16.2 | 1 SD above the mean on the FoP-Q-SF | |||
Hinz et al., 2015 [137] | 16.7 | Scale literature cut-off for FoP-Q-12 | |||
Jones et al., 2014 [5] | 23.4 | Scale literature on SHAI for “clinically signifikant health anxiety” | |||
Lebel et al., 2013 [38] | 58.3 | Established in FCRI literature for “clinically elevated fear of cancer recurrence” | |||
Liu et al., 2011 [61] | Sclae literature cut-off for CARS | ||||
24.8 | Moderate | ||||
4.3 | High | ||||
Mehnert et al., 2013 [41] | 18.1 | 1 SD above the mean on the FoP-Q-SF | |||
Petzel et al., 2012 [45] | 28–37 | Established in FCRI literature for “fear of cancer recurrence” | |||
Rylands et al.,2016 [156] | 23 | Highest quartile on seven-item scale | |||
Sarkar et al., 2014 [47] | 36 | ROC curve analyses for determination of cut-off for "high fear of recurrence" on the FoP-Q-SF | |||
Savard & Ivers, 2013 [48] | 44.0–56.1 | Scale literature for FCRI “clinical levels of fear of cancer recurrence” | |||
Simard & Savard, 2015 [68] | 42 | Clinical level of fear of cancer recurrence identified by interview SIFCR | |||
Thewes et al., 2013 [52] | 70 | Scale literature for FCRI “clinical levels of fear of cancer recurrence” | |||
Item severity (23) | 0–69.2 | Cho et al., 2017 [138] | Items means at “somewhat” or “very much” on ASC subscale fear of recurrence | ||
36.1 | Moderate to high | ||||
13 | High | ||||
Cutshall et al., 2015 [147] | 52 | One item fear of cancer recurrence response "somewhat or a lot bothersome" | |||
De Padova et al., 2011 [139] | One item fear of cancer recurrence | ||||
58 | None/a little | ||||
26 | Quite a lot | ||||
16 | A lot | ||||
De Vries et al., 2014 [34] | Responses to question "anxious about the possibility that the cancer may return": | ||||
11 | Not at all | ||||
74 | A little | ||||
11 | Somewhat | ||||
0 | A lot/very much | ||||
Fang et al., 2017 [148] | 48 | VAS used to identify "moderate" to "high" fear of cancer recurrence | |||
Fisher et al., 2016 [149] | 50 | "Agree" or "strongly agree" on the item "have fear about my cancer coming back" | |||
Handschel et al., 2012 [146] | Responses to one item on fear of recurrence: | ||||
19.5 | Not at all | ||||
30.1 | Little | ||||
27.9 | Moderate | ||||
16.1 | Strong | ||||
6.4 | Very strong | ||||
Janz et al., 2011 [151] | Mean on items assessing worry about recurrence: | ||||
14 | Not at all | ||||
32 | A little bit | ||||
25 | Somewhat | ||||
16 | Quite a bit | ||||
14 | Very much | ||||
Jones et al., 2017 [58] | Response to item about worry about cancer coming back or getting worse | ||||
16.2 | Never | ||||
24.5 | Rarely | ||||
39.7 | Sometimes | ||||
14.7 | Often | ||||
4.9 | All the time | ||||
Koch et al., 2014 [106] | Established on scale literature of FoP-Q-SF | ||||
82 | Low | ||||
11 | Moderate | ||||
6 | High | ||||
Koch-Gallenkamp et al., 2016 [59] | Established on scale literature of FoP-Q-SF | ||||
87 | Low | ||||
9 | Moderate | ||||
4 | High | ||||
Maguire et al., 2017 [62] | Score standardized 0 to 100 | ||||
61.0 | Scoring above 25 | ||||
18.6 | Scoring above 50 | ||||
Manne et al., 2016 [63] | Group-based trajectory model using CARS | ||||
25.5 | Low-stable | ||||
25.3 | High-decreasing | ||||
49.1 | High-stable | ||||
Matthew et al., 2017 [152] | Responses to author designed 5-item scale | ||||
36.8–62.2 | Not at all | ||||
48.8–51.2 | Mild | ||||
34.7–65.3 | Moderate | ||||
30.8–69.2 | Severe | ||||
Moye et al., 2014 [43] | Indicating "sometimes" to "always" for items: | ||||
44 | fear of cancer coming back | ||||
32.5 | fear of another cancer | ||||
39 | fear of future diagnostic tests | ||||
Myers et al., 2013 [145] | 47 | "Moderate-to-high" recurrence fears endorsed on CARS | |||
Ness et al., 2013 [141] | Indicating severity on item on fear of recurrence: | ||||
63 | Any level | ||||
17 | Extreme | ||||
O’Malley et al., 2017 [153] | Responses on single item on fear of cancer recurrence: | ||||
12.3 | Almost never | ||||
17.9 | Not very much | ||||
45.9 | Sometimes | ||||
23.9 | Very often | ||||
Pedersen et al., 2012 [142] | Indicating severity on item on worry about risk of recurrence: | ||||
47.2 | A little | ||||
19.3 | Quite a bit | ||||
8.5 | Very much | ||||
Rogers et al., 2016 [66] | New single item and 7-item scale assessing fear of recurrence | ||||
12 | Single item: No fear | ||||
49 | Single item: A little fear | ||||
29 | Single item: Sometimes having fearful thoughts | ||||
5 | Single item: A lot of fears | ||||
5 | Singel item: Fearful all the time | ||||
8–23 | 7-item measure: "a lot" or "all the time" | ||||
Rogers et al., 2017 [155] | Responses on single item measure on fear of recurrence: | ||||
9.3 | No fear | ||||
42.0 | A little fear | ||||
34.6 | Sometimes having fearful thoughts | ||||
9.3 | A lot of fear | ||||
4.9 | Fearful all the time | ||||
10–19 | Responses to seven item scale "a lot" or "all the time" | ||||
Smith et al., 2016 [157] | 30 | Reporting "very much" or "quite a bit" of fear of recurrence on single item | |||
Tewari et al., 2014 [143] | Severity of score on frequency of worrying about cancer coming back: | ||||
28.5 | Rarely | ||||
19.5 | Sometimes | ||||
5.2 | Often | ||||
1.9 | Always | ||||
Waters et al., 2013 [144] | Indicating on item “worried about progression”: | ||||
69.8 | Not at all | ||||
16.0 | A little | ||||
10.4 | Somewhat | ||||
3.3 | Quite a bit | ||||
0.4 | Very much | ||||
No cut-off (11) | 18–86 | Befort et al., 2011 [158] | 52 | Yes/no to “any fear of recurrence” from checklist of symptoms | |
Cheng et al., 2014 [162] | 18 | Reported unmet need of fears of cancer spreading | |||
Kanatas et al., 2013 [159] | 33 | Percentage of clinic appointments when fear of cancer coming back was mentioned | |||
Posluszny et al., 2016 [154] | 86 | "Yes"on at least one out of three yes/no items | |||
Schlairet, 2011 [160] | 73.2 | Participants identifying “fear of recurrence” | |||
Scott et al., 2013 [161] | 25–52 | Self-report for “any fear of cancer recurrence” | |||
Shay et al., 2016 [67] | 85.2/79.7 | Yes/no item on fear of recurrence in younger/ older cancer survivors | |||
Taylor et al., 2012 [49] | 67 | Minimal possible score of “at least some fear of recurrence” | |||
Van Liew et al., 2012 [136] | 60.1 | “Clinically significant levels of fear of recurrence” using FCRI with cut-off not reported | |||
van Londen et al., 2014 [163] | 67 | Yes/no fear of cancer recurrence identified as concern | |||
Wells et al., 2015 [164] | 48 | Report concerns of fear of cancer recurrence | |||
Not specified (3) | 51–80 | Moretto et al., 2014 [165] | 80 | Unspecified fear of recurrence | |
Naidoo et al., 2013 [166] | 69 | Unclear fear of recurrence | |||
Pandya et al., 2011 [167] | 51 | Unspecified feared recurrence | |||
Cardiac diseases (8) | 11–48.6 | ||||
Cut-off (2) | 31–48.6 | Bunz et al., 2016 [98] | 48.6 | 90th percentile of CAQ score in the general population | |
Hoyer et al., 2008 [90] | 31 | 2 SD above the mean of the non-cardiac comparison group for “clinically elevated cardiac anxiety” on CAQ | |||
Item severity (5) | 11–19 | Koivula et al., 2010 [171] | "High" fear on CHDPF items for fear of: | ||
19 | Uncertainty about illness | ||||
15 | Deterioration of coronary heart disease | ||||
12 | Myocardial infarction | ||||
Pauli et al., 1999 [173] | Fear of dying before AICD implantation: | ||||
59 | None | ||||
23 | Some | ||||
18 | Definite | ||||
Rosman et al., 2015 [99] | "Often" or "always" on CAQ items: | ||||
17.6 | If tests come out normal, I still worry about my heart. | ||||
14.6 | I worry that I may have a heart attack. | ||||
Schuster et al., 1998 [172] | Fear of death identified in concerns list: | ||||
62 | None | ||||
18 | Slight | ||||
10 | Moderate | ||||
3 | Quite a bit | ||||
8 | Extreme | ||||
van Beek et al., 2012 [96] | Groups identified by latent class analysis | ||||
30.4 | Continuously low | ||||
45.4 | Continuously medium | ||||
7.7 | Continuously high | ||||
16.5 | High-decreasing | ||||
No cut-off (1) | 16.6 | Pollack et al., 2005 [174] | 16.6 | Clinically relevant heart-focused anxiety on CAQ | |
Unspecified (0) | |||||
COPD (2) | 14–94.3 | ||||
Cut-off (0) | |||||
Item severity (1) | 14 | Stenzel et al., 2012 [168] | Mean on items assessing worry about recurrence: | ||
35 | No at all | ||||
34 | Slightly | ||||
17 | Moderate | ||||
14 | Strong/very strong | ||||
No cut-off (1) | 94.3 | Heffner et al., 1996 [169] | 94.3 | Identified health concern among many concerns | |
Diabetes (13) | 0–81 | ||||
Cut-off (9) | 0–81 | Anarte Ortiz et al., 2011 [30] | ROC curve analyses on FH-15 for “fear of hypoglycemia” using single item as criterion | ||
45.4 | FH-15 | ||||
48.0 | Single item | ||||
Belendez et al., 2009 [15] | 33 | Unclear cut-off on HFS for "being worried about developing hypoglycaemia" | |||
Claude et al., 2014 [7] | 24.1 | Established in literature of SHAI for “elevated health anxiety” | |||
Cox et al., 1998 [195] | 2 SD above published mean in worry scale of HFS | ||||
2 | Normally sighted | ||||
0 | Partially sighted | ||||
19 | Totally blind | ||||
Hajos et al., 2014 [196] | Four criteria to establish cut-off for “clinical fear of hypoglycemia” on HFS worry scale | ||||
81 | Modal distribution criterion | ||||
5 | SD criterion | ||||
31/21 | Concurrent validity criterion | ||||
26 | Elevated item endorsement criterion | ||||
Majanovic et al., 2017 [197] | 11.1 | Establisthed algorithm on elevated item endorsement on HFS-II worry subscale | |||
Nixon & Pickup, 2011 [198] | 27 | Score > 50% of total possible score “substantial fear of hypoglycemia” | |||
Shiu & Wong, 2000 [199] | 15 | Cut-off > 30 on HFS for "high fear of hypoglycemia" | |||
van Beers et al., 2017 [204] | 25 | 1 SD above mean in worry scale of HFS | |||
Item severity (2) | 27.7–77 | Martyn-Nemeth et al., 2017 [200] | HFS for assessment of "trait fear of hypglycemia" and daily-diary recorded fear of hypoglycaemia | ||
51 | Worry becoming hypoglycemic while sleeping | ||||
77 | High daily fear (score 4/5 on two 1–5 items) at least once during six-day study period | ||||
Sakane et al., 2015 [203] | 27.7 | "Fear of hypoglycemia" was defined as the highest quintile on single item | |||
No cut-off (1) | 30 | Myers et al., 2007 [201] | 30 | HFS "fear of death from hypoglycemia" | |
Unspecified (1) | 62.9 | Riaz et al., 2014 [202] | 62.9 | Reported “fear of hypoglycemia” | |
Epilepsy (1) | 45.5 | ||||
Cut-off (0) | |||||
Item severity (0) | |||||
No cut-off (1) | |||||
Unspecified (0) | 45.5 | Mameniskiene et al., 2015 [205] | 45.5 | Constant fear of the next seizure | |
Hepatitis (1) | 25–44 | ||||
Cut-off (0) | |||||
Item severity (0) | |||||
No cut-off (1) | 25–44 | Alizadeh et al., 2008 [194] | Prinicipal concern: | ||
25 | Developing liver cancer | ||||
44 | Disease progression to cirrhosis | ||||
Unspecified (0) | |||||
HIV/AIDS (2) | 9.4–76.2 | ||||
Cut-off (0) | |||||
Item severity (1) | Sarna et al., 1999 [132] | 76.2 | Indicating "a fair amount" to "very much" on item "worry whether HIV is progressing" | ||
No cut-off (1) | Kemppanien et al., 2003 [133] | Any indication of "fealing anxious": | |||
9.4 | About the onset of new symptoms | ||||
18.9 | About death | ||||
Multiple sclerosis /neuromuscular disorders (4) | 24.9–63.5 | ||||
Cut-off (3) | 24.9–60.3 | Kalron & Achiron, 2014 [102] | Results of ROC analysis of FES-I in another study identifying fear of falling | ||
39.7 | Slightly concerned | ||||
60.3 | Highly concerned | ||||
Kehler et al., 2009 [175] | 24.9 | Scale literature of SHAI for “elevated health anxiety” | |||
Pieterse et al., 2006 [179] | 58 | Scale literature of FES for “fear of falling” | |||
Item severity (1) | 63.5 | Peterson et al., 2007 [192] | 63.5 | Yes/no to question "are you concerend about falling" | |
No cut-off (0) | |||||
Unspecified (0) | |||||
Parkinson’s disease (22) | 7–89 | ||||
Cut-off (7) | 25–48 | Allen et al., 2012 [176] | 45.7 | Scale literature of FES-I for “high fear of falling" | |
Bryant et al., 2014 [71] | 44.3 | Established in literature for ABC “high fear of falling” | |||
Chomiak et al., 2015 [177] | 25 | Scale literature of FES-I for "high fear of falling" | |||
Franzen et al., 2016 [78] | Scale literature of FES-I for fear of falling | ||||
12 | Low | ||||
39 | Moderate | ||||
48 | High | ||||
Jonasson et al., 2015 [79] | Scale literature on FES-I for levels of fear of falling | ||||
29 | Low | ||||
58 | Moderate | ||||
47 | High | ||||
Landers et al., 2014 [178] | 46.4 | Cut-off ≥20 on FABQ for "fear of falling avoidance behavior" | |||
O’Connell & Guidon, 2016 [82] | 45.2 | Scale literature of ABC for “high fear of falling" | |||
Item severity (1) | 14 | Grimbergen et al., 2013 [180] | Single item on fear of falling | ||
41 | No | ||||
45 | Somewhat | ||||
14 | Very | ||||
No cut-off (10) | 35–89 | Combs et al., 2014 [181] | 44 | Yes/no to feeling worried about falling | |
Dennison et al., 2007 [182] | 35 | Yes/no to item “any fear of falling” | |||
Jonasson et al., 2014 [183] | 55 | Yes/no to item “fear of falling” | |||
Kader et al., 2016 [184] | 48 | Yes/no to item "are you afraid of falling" | |||
Kataoka et al., 2011 [185] | 83 | Present or not at any level “fear of falling” | |||
Lindholm et al., 2014 [73] | 37 | Yes/no to item “any fear of falling” | |||
Nilsson et al., 2010 [74] | 43 | Yes/no to item “fear of falling” | |||
Nilsson et al., 2010 [186] | 38 | Yes/no to item “fear of falling” | |||
Nilsson et al., 2012 [75] | 45 | Yes/no to item “fear of falling” | |||
Thomas et al., 2010 [187] | 89 | At least some fear of falling on FES | |||
Unspecified (4) | 7–83.7 | Bloem et al., 2001 [188] | 45.8 | Any fear of falling indicated in clinical interview | |
Cubo et al., 2012 [189] | 53 | Fear of falling assessed with structured questionaires and ABC | |||
Lindholm et al., 2015 [190] | 83.7 | Not specified | |||
Pasman et al., 2011 [191] | 7–15 | Not specified: fear of falling during three experimental conditions | |||
Stroke (3) | 7.4–56 | ||||
Cut-off (1) | 19 | Guan et al., 2015 [170] | 19 | ABC scale cut-off from validation literature of healthy population | |
Item severity (2) | 7.4–56 | Noble et al., 2011 [105] | Reporting "Extremely fearful" on single item “fear of another haemorrhage” | ||
7.4 | Patients without PTSD | ||||
32.1 | Patients with PTSD | ||||
Townend et al., 2006 [193] | 56 | "Agree"/"strongly agree" on item “worry about my stroke returning” | |||
No cut-off (0) | |||||
Unspecified (0) |
In articles that reported longitudinal outcomes, we have reported the baseline findings. Among item severity scores, we have indicated the range of prevalence of highest possible scores.
ABC = Activities-specific Balance Confidence Scale; ASC = Assessment of Survivor Concerns; AICD = Automatic Implantable Cardioverter Defibrillator; CHDPF = Coronary Heart Disease Patients Fear Scale; CARS = Concerns About Recurrence Scale; CAS = Cancer Acceptance Scale; CAQ = Cardiac Anxiety Questionnaire; CWS = Cancer Worry Scale; FABQ = Fall Avoidance Behaviour Questionnaire; FCRI = Fear of Cancer Recurrence Inventory; FES = Falls Efficacy Scale; FES-I = Falls Efficacy Scale–International; FH-15 = Fear of Hypoglycemia 15-item Scale; FoP-Q-SF = Fear of Progression Questionnaire-Short Form; HFS = Hypoglycemia Fear Survey; MAX-PC = Memorial Anxiety Sclae for Prostate Cancer; PTSD = Posttraumatic Stress Disorder; ROC = Receiver operating characteristic; SD = standard deviation; SHAI = Short Health Anxiety Inventory; SIFCR = Semi-Structured Interview on Fear of Cancer Recurrence; VAS = Visual Analogue Scale